Search details
1.
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.
Invest New Drugs
; 37(4): 674-683, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30411218
2.
Phase I study of lurbinectedin, a synthetic tetrahydroisoquinoline that inhibits activated transcription, induces DNA single- and double-strand breaks, on a weekly × 2 every-3-week schedule.
Invest New Drugs
; 35(4): 471-477, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28105566
Results
1 -
2
de 2
1
Next >
>>